Key publications
All Publications
- Verberne Hein J., Brewster Lizzy M., Somsen G. Aernout, van Eck-Smit Berthe L. F. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review European heart journal 2008;29 (9):1147-1159 [PubMed]
- Verberne Hein J., Sokole Ellinor Busemann, van Moerkerken Astrid F., Deeterink Joop H. W. M., Ensing Geert, Stabin Michael G., Somsen G. Aernout, van Eck-Smit Berthe L. F. Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added I-123-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity European journal of nuclear medicine and molecular imaging 2008;35 (4):798-807 [PubMed]
- van Beers Eduard J., van Eck-Smit Berthe L. F., Mac Gillavry Melvin R., van Tuijn Charlotte F. J., van Esser Joost W. J., Brandjes Dees P. M., Kappers-Klunne Mies C., Duits Ashley J., Biemond Bart J., Schnog John-John B. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension Chest 2008;133 (3):646-652 [PubMed]
- Verberne Hein J., de Bruin Kora, Habraken Jan B. A., Somsen G. Aernout, Eersels Jos L. H., Moet Frits, Booij Jan, van Eck-Smit Berthe L. F. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity European journal of nuclear medicine and molecular imaging 2006;33 (4):483-490 [PubMed]
- Campian Maria E., Verberne Hein J., Hardziyenka Maxim, de Bruin Kora, Selwaness Mariana, van den Hoff Maurice J. B., Ruijter Jan M., van Eck-Smit Berthe L. F., de Bakker Jacques M. T., Tan Hanno L. Serial Noninvasive Assessment of Apoptosis During Right Ventricular Disease Progression in Rats Journal of nuclear medicine 2009;50 (8):1371-1377 [PubMed]
Research programmes
Prof. PhD B.L.F. Smit (Molecular imaging from mice to men)
- characterization studies of newly developed radiotracers, which have the potential to become useful in futute human studies.
- molecular imaging in small laboratory animals for the characterization of newly developed radiotracers, especially for the detection of unstable atherosclerotic plaques.
- molecular imaging in small laboratory animals for the assessment of pathophysiologic pathways in cardiac diseases, especially in heart failure.
- Clinical molecular imaging, especially in patients with ischemic heart disease and heart failure.
- Clinical molecular imaging using radiotracers.